Cargando…
Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study
BACKGROUND: COVID-19 vaccines have proven safe and efficacious in reducing severe illness and death. Cuban protein subunit vaccine Abdala has shown safety, tolerability and efficacy (92·3% [95% CI: 85·7‒95·8]) against SARS-CoV-2 in clinical trials. This study aimed to estimate Abdala's real-wor...
Autores principales: | Más-Bermejo, Pedro I., Dickinson-Meneses, Félix O., Almenares-Rodríguez, Kenia, Sánchez-Valdés, Lizet, Guinovart-Díaz, Raúl, Vidal-Ledo, María, Galbán-García, Enrique, Olivera-Nodarse, Yadira, Morgado-Vega, Isabel, Dueñas-Carrera, Santiago, Pujol, Merardo, Hernández-Bernal, Francisco, Limonta-Fernández, Miladys, Guillén-Nieto, Gerardo, Muzio-González, Verena L., Ayala-Ávila, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9507841/ https://www.ncbi.nlm.nih.gov/pubmed/36185968 http://dx.doi.org/10.1016/j.lana.2022.100366 |
Ejemplares similares
-
Correction to “Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study” [The Lancet Regional Health – Americas 2022; 16: 100366] https://doi.org/10.1016/j.lana.2022.100366
por: Más-Bermejo, Pedro I., et al.
Publicado: (2022) -
CUBAN VACCINES ABDALA AND MAMBISA AGAINST COVID-19
por: Guillen, G., et al.
Publicado: (2023) -
Phylogenetic Identification, Diversity, and Richness of Aspergillus from Homes in Havana, Cuba
por: Sánchez Espinosa, Kenia C., et al.
Publicado: (2021) -
Impressions of Cuba and the Cubans
por: Clinton, Marshall
Publicado: (1899) -
Multicenter Study of Carbapenemase-Producing Enterobacterales in Havana, Cuba, 2016–2021
por: Yu, Haiyang, et al.
Publicado: (2022)